MedTrace Logo

A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema

NCT01541423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 83

Last updated 2021-03-17

No results posted yet for this study

Summary

This observational (non-interventional) study is being conducted to characterize the safety and use of CINRYZE in routine clinical practice when administered for (1) routine prevention of angioedema attacks, (2) pre-procedure prevention of angioedema attacks, and/or (3) treatment of angioedema attacks.

Conditions

  • Hereditary Angioedema (HAE)

Sponsors & Collaborators

  • Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-11
Primary Completion
2016-09-25
Completion
2016-09-25

Countries

  • Belgium
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01541423 on ClinicalTrials.gov